FHCCX — Fidelity Advisor Health Care Fund
Data updated: 2026-06-26
FHCCX — Fidelity Advisor Health Care Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $2.89B AUM · 1.68% expense ratio · 10.4% 1-yr return. From SEC regulatory filings.
FHCCX Fund Overview
FHCCX — Fidelity Advisor Health Care Fund is a US mutual fund managed by Fidelity Advisor Series VII, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Fidelity Advisor Series VII
- Category: United States Health Care Equity
- Assets under management: $2.89B
- 1-year return: 10.4%
- Ticker: FHCCX
- SEC CIK: 0000315700
- SEC series ID: S000005329
- Share class ID: C000014561
FHCCX Holdings
Top 10 holdings of Fidelity Advisor Health Care Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| ELI LILLY and CO | 6.93% |
| Danaher Corp. | 6.79% |
| JOHNSON and JOHNSON | 5.67% |
| Thermo Fisher Scientific, Inc. | 3.62% |
| Unitedhealth Group, Inc. | 3.02% |
| Boston Scientific Corp. | 2.79% |
| Ascendis Pharma A/s | 2.70% |
| Alnylam Pharmaceuticals, Inc. | 2.44% |
| Gilead Sciences, Inc. | 2.27% |
| Abbvie, Inc. | 2.23% |
FHCCX Portfolio Allocation
Asset-class allocation of Fidelity Advisor Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 1.5% |
| Fixed Income | 0.2% |
FHCCX Performance
Total returns for FHCCX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -5.0% |
| 1 year | 10.4% |
| 3 years (annualised) | -3.8% |
| 5 years (annualised) | -8.2% |
FHCCX Risk Information
Risk metrics for FHCCX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.3%
FHCCX Costs and Fees
FHCCX costs about $168 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.68%
- Gross expense ratio: 1.68%
- Portfolio turnover: 52%
- Brokerage commissions: 2.58 bps of average net assets (SEC N-CEN)
FHCCX Cashflows
Over the 12 months to 2026-04, Fidelity Advisor Health Care Fund had net outflows of $652.68M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$68.08M |
| 2026-03 | −$52.60M |
| 2026-02 | −$86.52M |
| 2026-01 | −$62.01M |
| 2025-12 | $282.88M |
| 2025-11 | −$53.27M |
FHCCX Debt Constituents
Largest debt holdings of Fidelity Advisor Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Kardium Inc/us | 0.10% |
| Wugen, Inc. | 0.05% |
| Galvanize Therapeutics | 0.03% |
FHCCX Prospectus and SEC Filings
Official Fidelity Advisor Health Care Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.